These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 27628744)
1. Secretin-stimulated MR cholangiopancreatography: spectrum of findings in pancreatic diseases. Boraschi P; Donati F; Cervelli R; Pacciardi F Insights Imaging; 2016 Dec; 7(6):819-829. PubMed ID: 27628744 [TBL] [Abstract][Full Text] [Related]
2. Secretin-enhanced MR Imaging of the Pancreas. Manfredi R; Pozzi Mucelli R Radiology; 2016 Apr; 279(1):29-43. PubMed ID: 26989929 [TBL] [Abstract][Full Text] [Related]
3. Diagnosis of early-stage chronic pancreatitis by secretin-enhanced magnetic resonance cholangiopancreatography. Czakó L J Gastroenterol; 2007 Jan; 42 Suppl 17():113-7. PubMed ID: 17238039 [TBL] [Abstract][Full Text] [Related]
4. Non-invasive quantification of pancreatic exocrine function using secretin-stimulated MRCP. Punwani S; Gillams AR; Lees WR Eur Radiol; 2003 Feb; 13(2):273-6. PubMed ID: 12598990 [TBL] [Abstract][Full Text] [Related]
5. MR imaging of the pancreas: a pictorial tour. Matos C; Cappeliez O; Winant C; Coppens E; Devière J; Metens T Radiographics; 2002; 22(1):e2. PubMed ID: 11796914 [TBL] [Abstract][Full Text] [Related]
6. Pancreas divisum and "santorinicele": diagnosis with dynamic MR cholangiopancreatography with secretin stimulation. Manfredi R; Costamagna G; Brizi MG; Spina S; Maresca G; Vecchioli A; Mutignani M; Marano P Radiology; 2000 Nov; 217(2):403-8. PubMed ID: 11058635 [TBL] [Abstract][Full Text] [Related]
7. Administration of secretin (RG1068) increases the sensitivity of detection of duct abnormalities by magnetic resonance cholangiopancreatography in patients with pancreatitis. Sherman S; Freeman ML; Tarnasky PR; Wilcox CM; Kulkarni A; Aisen AM; Jacoby D; Kozarek RA Gastroenterology; 2014 Sep; 147(3):646-654.e2. PubMed ID: 24906040 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the stimulating effect of a low dose of secretin compared to the standard dose on the exocrine pancreas with MRCP: preliminary results in normal subjects (MRCP quantification of secretin stimulation). Bali MA; Sontou R; Arvanitakis M; Metens T; Devière J; Matos C Abdom Imaging; 2007 Nov; 32(6):743-8. PubMed ID: 17253108 [TBL] [Abstract][Full Text] [Related]
17. Choledochal cysts: comparison of findings at MR cholangiopancreatography and endoscopic retrograde cholangiopancreatography in eight patients. Matos C; Nicaise N; Devière J; Cassart M; Metens T; Struyven J; Cremer M Radiology; 1998 Nov; 209(2):443-8. PubMed ID: 9807571 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic yield of ERCP and secretin-enhanced MRCP and EUS in patients with acute recurrent pancreatitis of unknown aetiology. Mariani A; Arcidiacono PG; Curioni S; Giussani A; Testoni PA Dig Liver Dis; 2009 Oct; 41(10):753-8. PubMed ID: 19278909 [TBL] [Abstract][Full Text] [Related]
19. Secretin Improves Visualization of Nondilated Pancreatic Ducts in Children Undergoing MRCP. Li Y; Dillman JR; Anton CG; Crotty EJ; Smith EA; Abu-El-Haija M; Trout AT AJR Am J Roentgenol; 2020 Apr; 214(4):917-922. PubMed ID: 32023119 [No Abstract] [Full Text] [Related]
20. Correlation between secretin-enhanced MRCP findings and histopathologic severity of chronic pancreatitis in a cat model. Zhang TT; Wang L; Wang DB; Huang ZJ; Li YH; Lu JP Pancreatology; 2013; 13(5):491-7. PubMed ID: 24075513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]